Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Established in 1993 and headquartered in Navi Mumbai, India, 3i Infotech Limited specializes in providing intellectual property-based software and a comprehensive suite of information technology services. The company boasts a significant international presence, operating across India, North America, the Asia Pacific, the Middle East, Africa, the Kingdom of Saudi Arabia, and South Asia. Its diverse product portfolio features NuRe Edge, a consolidated platform for secure access services; NuRe desk, a next-generation virtual desktop leveraging a powerful virtualization engine; NuRe 3i, focused on designing, building, and managing full-stack cloud solutions, including maintaining vital operational applications within cloud environments; and NuRe 3i+, an enterprise-grade cloud converged infrastructure facilitating the consolidation of critical middleware and application workloads on Oracle OCI or at the edge. Additional offerings include MAGGIET, an integrated intelligent process automation solution; Flexib, a unique digital testing platform accelerating QAOps for functional and non-functional test automations in both DevOps and non-DevOps settings; Momenta, an analytics solution equipped with integrated AI and data science capabilities; the 3iAires Suite, designed to digitize core enterprise processes and orchestrate a consistent brand experience across all engagement channels; and Universo, a modular and configurable scheme management solution developed with Open Source technologies to automate the entire scheme lifecycle from beneficiary management to benefit disbursement and reconciliation. 3i Infotech serves a wide array of industry verticals, including banking, insurance, capital markets, asset and wealth management, government, manufacturing, retail, distribution, telecommunications, and healthcare.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably